New Treatment Perspectives for Acute Relapses in Neuromyelitis Optica Spectrum Disorder
Authors:
- 27 August 2022
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 36 (4) , 230-232
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Immunology of neuromyelitis optica: a T cell–B cell collaborationAnnals of the New York Academy of Sciences, 2013
- Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotypeNeurology, 2012
- Epidemiology of Neuromyelitis Optica in the United StatesArchives of Neurology, 2012
- Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory diseaseJournal of Clinical Investigation, 2012
- Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoproteinMultiple Sclerosis Journal, 2012
- Neutrophil protease inhibition reduces neuromyelitis optica–immunoglobulin G–induced damage in mouse brainAnnals of Neurology, 2011
- Sera from neuromyelitis optica patients disrupt the blood–brain barrierJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis opticaProceedings of the National Academy of Sciences of the United States of America, 2011
- The paradoxical effect of bevacizumab in the therapy of malignant gliomasNeurology, 2011
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007